18-23544402-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000271.5(NPC1):c.2072C>A(p.Pro691Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P691L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPC1 | NM_000271.5 | c.2072C>A | p.Pro691Gln | missense_variant | 13/25 | ENST00000269228.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPC1 | ENST00000269228.10 | c.2072C>A | p.Pro691Gln | missense_variant | 13/25 | 1 | NM_000271.5 | P1 | |
NPC1 | ENST00000591051.1 | c.1151C>A | p.Pro384Gln | missense_variant | 6/18 | 2 | |||
NPC1 | ENST00000540608.5 | n.1986C>A | non_coding_transcript_exon_variant | 11/16 | 2 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Niemann-Pick disease, type C Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 24, 2023 | Variant summary: NPC1 c.2072C>A (p.Pro691Gln) results in a non-conservative amino acid change located in the sterol-sensing domain (IPR000731) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251440 control chromosomes (gnomAD). c.2072C>A has been reported in the literature in the compound heterozygous state in individuals diagnosed with Niemann-Pick Disease Type C, including at least one case where it was confirmed to be in trans with a pathogenic variant (e.g. Mazzacuva_2016, Sparks_2020, Kingsmore_2022). These data indicate that the variant is likely associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, other variants affecting the same amino acid (P691L and P691A) have been classified as pathogenic/likely pathogenic in ClinVar, suggesting this residue is important for protein function. One submitter has provided a clinical-significance assessment for this variant to ClinVar after 2014 and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Sphingomyelin/cholesterol lipidosis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | Sep 25, 2019 | This variant has not been previously reported or functionally characterized in the literature to our knowledge. However, a different amino acid change at the same position has been reported as likely pathogenic in the ClinVar database by a clinical laboratory (Variation ID: 552803). It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. The c.2072C>A (p.Pro691Gln) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. This result was confirmed by Sanger sequencing. Analysis of the parental samples showed the mother is negative and the father is heterozygous for this variant. Based on the available evidence, the c.2072C>A (p.Pro691Gln) variant is classified as Likely Pathogenic. - |
Niemann-Pick disease, type C1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Aug 29, 2023 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 691 of the NPC1 protein (p.Pro691Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with NPC1-related conditions (PMID: 27139891, 33027564, 36007526). ClinVar contains an entry for this variant (Variation ID: 986365). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function. This variant disrupts the p.Pro691 amino acid residue in NPC1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12955717, 25236789, 27139891). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at